BACKGROUND: Recent clinical trial data support a pharmacoinvasive strategy as an alternative to primary percutaneous coronary intervention (pPCI) in ST-segment elevationmyocardial infarction. We evaluated whether this is true in a real-world prehospital ST-segment elevationmyocardial infarctionnetwork using ECG assessment of reperfusion coupled with clinical outcomes within 1 year. Of the 5583 ST-segment elevationmyocardial infarctionpatients in the Alberta Vital Heart Response Program (Cohort 1 [2006-2011]: n=3593; Cohort 2 [2013-2016]: n=1990), we studied 3287 patients who received a pharmacoinvasive strategy with tenecteplase (April 2013: half-dose tenecteplase was employed in prehospital patients 75 years) or pPCI Continue reading →

For this group of Sanders supporters, all members of a local chapter of the progressive organization Our Revolution, assessing his performance was important. But abandoning him was never actually an option: The promise of a political revolution is worth supporting a 78-year-old who just suffered a myocardial infarction. Continue reading →

Democratic presidential candidate Bernie Sanders took to Twitter to thank well-wishers after he was released from a Las Vegas hospital Friday. His campaign confirmed that Sanders had a heart attack. Continue reading →

Reports Monitor has the addition of a new report titled, Global Myocardial Infarction Therapeutics Market provides an in-depth study about the market size, share, industry focus, industry status, competitive landscape, and the potential future growth opportunity of the market. The report also offers a detailed valuation of the future technologies on the basis of the historical and on-going market data as well as the dynamics of the market. Continue reading →

The global cardiac biomarkers testing market has witnessed significant growth in the past few years and is anticipated to continue to grow at a consistent pace, due to the high prevalence of cardiac diseases that widely remain undiagnosed. A large number of cardiac biomarkers in the pipeline augmented patient awareness toward the importance of early detection of cardiovascular diseases, and opportunities in untapped countries such as India, China, and other Asia-Pacific countries are the key factors that contribute toward the growth of the market. Continue reading →